About Peroxisome assembly protein 12
Peroxisome assembly protein 12 (PEX12) is a protein
from Homo sapiens identified by UniProt accession
O00623, 359 residues long.
MolForge cross-references it against 0 known binders and
33 disease associations.
Target properties
| Protein name | Peroxisome assembly protein 12 |
| UniProt accession | O00623 |
| Gene | PEX12 |
| Organism | Homo sapiens |
| Length | 359 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (33)
Diseases linked to this target (Open Targets).
- peroxisome biogenesis disorder type 3B · score 0.80
- peroxisome biogenesis disorder 3A (Zellweger) · score 0.79
- Peroxisome biogenesis disorder-Zellweger syndrome spectrum · score 0.67
- peroxisome biogenesis disorder · score 0.67
- Zellweger syndrome · score 0.62
- neurodegenerative disease · score 0.43
- genetic disorder · score 0.41
- peroxisome biogenesis disorder, complementation group 7 · score 0.37
- reticulocyte count · score 0.31
- reticulocyte measurement · score 0.30
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O00623-F1 | alphafold | PREDICTED | 81.04 | — |
Amino-acid sequence (359 residues)
MAEHGAHFTA ASVADDQPSI FEVVAQDSLM TAVRPALQHV VKVLAESNPT HYGFLWRWFD EIFTLLDLLL QQHYLSRTSA SFSENFYGLK RIVMGDTHKS QRLASAGLPK QQLWKSIMFL VLLPYLKVKL EKLVSSLREE DEYSIHPPSS RWKRFYRAFL AAYPFVNMAW EGWFLVQQLR YILGKAQHHS PLLRLAGVQL GRLTVQDIQA LEHKPAKASM MQQPARSVSE KINSALKKAV GGVALSLSTG LSVGVFFLQF LDWWYSSENQ ETIKSLTALP TPPPPVHLDY NSDSPLLPKM KTVCPLCRKT RVNDTVLATS GYVFCYRCVF HYVRSHQACP ITGYPTEVQH LIKLYSPEN
Explore Peroxisome assembly protein 12 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets